Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises 1Vision Biogas on its public offer for Biokraft
Mandate

Vinge advises 1Vision Biogas on its public offer for Biokraft

February 05, 2024 Capital Markets and Public M&A M&A FDI EU, Competition and Regulatory

1Vision Biogas AB, a company controlled by Aneo, HitecVision and St1, has made a public mandatory bid for all shares in Biokraft International AB. The offer values the shares of Biokraft at approximately SEK 900 million. Vinge advises 1Vision Biogas.

The Vinge team includes Christian Lindhé, Erik Sjöman, Martin Madsen Svanberg, Johan Åhman and Johan Severinsson (Capital Markets and Public M&A), Jesper Ottergren (M&A) as well as Sofie Nordgren, Pär Remnelid, Rikard Azelius and Jasmine Elgh (FDI/EU, Competition and Regulatory).

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

 Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025